Alkem Laboratories (NSE:ALKEM) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Alkem Laboratories FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Alkem Laboratories's Free Cash Flow for the three months ended in Dec. 2023 was ₹0 Mil. Alkem Laboratories's Revenue for the three months ended in Dec. 2023 was ₹33,239 Mil. Therefore, Alkem Laboratories's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Alkem Laboratories's current FCF Yield % is 2.35%.

The historical rank and industry rank for Alkem Laboratories's FCF Margin % or its related term are showing as below:

NSE:ALKEM' s FCF Margin % Range Over the Past 10 Years
Min: -6.63 Med: 5.56 Max: 12.67
Current: 11.62

During the past 13 years, the highest FCF Margin % of Alkem Laboratories was 12.67%. The lowest was -6.63%. And the median was 5.56%.

NSE:ALKEM's FCF Margin % is ranked better than
79.01% of 1029 companies
in the Drug Manufacturers industry
Industry Median: -0.47 vs NSE:ALKEM: 11.62

Alkem Laboratories FCF Margin % Historical Data

The historical data trend for Alkem Laboratories's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alkem Laboratories FCF Margin % Chart

Alkem Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

FCF Margin %

Get a 7-Day Free Trial

3.45

2.71

12.26

7.35

12.67

Alkem Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Alkem Laboratories's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Alkem Laboratories's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alkem Laboratories's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alkem Laboratories's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Alkem Laboratories's FCF Margin % falls into.

Alkem Laboratories FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Alkem Laboratories's FCF Margin for the fiscal year that ended in Mar. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	14495.9	/	114403.5
	=	12.67 %

Alkem Laboratories's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	33238.7
	=	0.00 %

Alkem Laboratories FCF Margin % Related Terms

Thank you for viewing the detailed overview of Alkem Laboratories's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Alkem Laboratories (NSE:ALKEM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkem Laboratories Ltd (NSE:ALKEM) » Definitions » FCF Margin %

Traded in Other Exchanges

539523:India

Address

Senapati Bapat Marg, Alkem House, Devashish Building, Lower Parel, Mumbai, MH, IND, 400 013

Website

https://www.alkemlabs.com

Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas, such as anti-infective, pain and analgesics, vitamins/minerals/nutrients, cardiac and Diabetology, Gynecology, neuro/central nervous system, dermatology, anti-diabetes, anti-osteoporosis, cardiovascular, and muscle relaxants, which are marketed in Indian and International markets. It operates through the pharmaceutical business segment.

Alkem Laboratories (NSE:ALKEM) Headlines

No Headlines